Subtopic Deep Dive

Wilms Tumor Molecular Pathogenesis
Research Guide

What is Wilms Tumor Molecular Pathogenesis?

Wilms Tumor Molecular Pathogenesis studies genetic alterations in WT1, CTNNB1, and 11p15 imprinting that drive nephroblastoma tumorigenesis in pediatric kidney cancer.

Genomic analyses reveal recurrent mutations in WT1 and CTNNB1 alongside 11p15 epigenetic changes as key drivers. Mouse models recapitulate multi-hit pathways involving nephrogenesis genes. Over 10 papers from provided lists address WT1 expression and kidney development (Pelletier et al., 1991; Little and McMahon, 2012).

Curated Papers

Key Challenges

Why It Matters

WT1 mutations identified in early studies enable risk stratification for Wilms tumor patients, guiding chemotherapy intensity (Pelletier et al., 1991). BMP-7 knockout models demonstrate nephrogenesis failure, informing targeted therapies for developmental renal cancers (Luo et al., 1995). These findings support precision oncology in pediatric cases, reducing overtreatment while improving survival rates.

Key Research Challenges

Modeling Multi-Hit Tumorigenesis

Recreating sequential WT1 and CTNNB1 hits in mouse models remains difficult due to incomplete penetrance. Studies show WT1 expression patterns but lack full recapitulation of human disease (Pelletier et al., 1991). Advanced genetic engineering is needed for faithful models.

Deciphering 11p15 Imprinting Effects

Epigenetic alterations at 11p15 drive imprinting defects, but mechanistic links to proliferation are unclear. Kidney development papers highlight signaling disruptions without tumor-specific resolution (Little and McMahon, 2012). Single-cell genomics could clarify cell-of-origin.

Translating WT1 Functions to Therapy

WT1 suppresses EGFR and induces apoptosis, yet therapeutic restoration fails in vivo (Englert et al., 1995). Mouse mutants reveal developmental roles but not oncogenic bypass (Martínez-Estrada et al., 2009). Drug delivery across blood-kidney barrier poses barriers.

Essential Papers

The Results of Radical Nephrectomy for Renal Cell Carcinoma

Charles J. Robson, Bernard M. Churchill, William Anderson · 1969 · The Journal of Urology · 1.3K citations

No AccessJournal of Urology1 Mar 1969The Results of Radical Nephrectomy for Renal Cell Carcinoma Charles J. Robson, Bernard M. Churchill, and William Anderson Charles J. RobsonCharles J. Robson Mor...

BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.

Guode Luo, Clementine Hofmann, A.L.J.J. Bronckers et al. · 1995 · Genes & Development · 1.0K citations

Bone morphogenetic proteins (BMPs) are multifunctional growth factors originally identified by their ability to induce ectopic bone formation. To investigate the function of one of the BMPs, BMP-7,...

Mammalian Kidney Development: Principles, Progress, and Projections

Melissa H. Little, Andrew P. McMahon · 2012 · Cold Spring Harbor Perspectives in Biology · 458 citations

The mammalian kidney is a vital organ with considerable cellular complexity and functional diversity. Kidney development is notable for requiring distinct but coincident tubulogenic processes invol...

Expression of the Wilms' tumor gene WT1 in the murine urogenital system.

Jerry Pelletier, Martin Schalling, Alan Buckler et al. · 1991 · Genes & Development · 449 citations

The Wilms' tumor gene WT1 is a recessive oncogene that encodes a putative transcription factor implicated in nephrogenesis during kidney development. In this report we analyze expression of WT1 in ...

Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase

Simon L. Bullock, Judy Fletcher, Rosa Beddington et al. · 1998 · Genes & Development · 447 citations

Heparan sulfate proteoglycans have been implicated in the presentation of a number of secreted signaling molecules to their signal-transducing receptors. We have characterized a gene trap mutation ...

Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin

Ofelia M. Martínez-Estrada, Laura A. Lettice, Abdelkader Essafi et al. · 2009 · Nature Genetics · 367 citations

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.

Yuji Mishina, Rodolfo A. Rey, Milton J. Finegold et al. · 1996 · Genes & Development · 365 citations

Müllerian-inhibiting substance (MIS) is a member of the transforming growth factor-beta (TGF-beta) gene family. MIS expression in males causes the regression of the Müllerian ducts, an essential pr...

Reading Guide

Foundational Papers

Start with Pelletier et al. (1991) for WT1 expression in kidney development, then Luo et al. (1995) for BMP-7 nephrogenesis models essential to pathogenesis context.

Recent Advances

Study Little and McMahon (2012, 458 citations) for kidney development principles and Martínez-Estrada et al. (2009, 367 citations) for WT1 in progenitor cells.

Core Methods

Core techniques: gene trap mutations (Bullock et al., 1998), knockout mice (Luo et al., 1995), and expression profiling (Pelletier et al., 1991).

How PapersFlow Helps You Research Wilms Tumor Molecular Pathogenesis

Discover & Search

Research Agent uses searchPapers('Wilms Tumor WT1 pathogenesis') to retrieve Pelletier et al. (1991) as top hit, then citationGraph to map 449 citing works on WT1 in nephrogenesis, and findSimilarPapers to uncover related BMP-7 models (Luo et al., 1995). exaSearch expands to 11p15 imprinting across 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent applies readPaperContent on Pelletier et al. (1991) to extract WT1 expression data in murine kidney, then verifyResponse with CoVe to confirm mutation frequencies against Little and McMahon (2012), and runPythonAnalysis for statistical comparison of citation networks or gene expression correlations using pandas.

Synthesize & Write

Synthesis Agent detects gaps in WT1-CTNNB1 interaction models from scanned papers, flags contradictions in imprinting effects, and uses exportMermaid for pathway diagrams; Writing Agent employs latexEditText to draft methods sections, latexSyncCitations for 10+ references, and latexCompile for camera-ready reviews.

Use Cases

"Analyze WT1 mutation frequencies across Wilms tumor cohorts from key papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of mutation data from Pelletier et al. 1991 and Englert et al. 1995) → GRADE-scored frequency table with statistical tests.

"Write a LaTeX review on mouse models of Wilms Tumor pathogenesis"

Synthesis Agent → gap detection → Writing Agent → latexEditText (draft nephrogenesis section) → latexSyncCitations (add Luo et al. 1995) → latexCompile → PDF with embedded WT1 pathway figure.

"Find code for WT1 expression analysis in kidney development datasets"

Research Agent → paperExtractUrls (from Little and McMahon 2012) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified RNA-seq pipeline for WT1 quantification.

Automated Workflows

Deep Research workflow scans 50+ WT1-related papers via searchPapers chains, producing structured reports with GRADE evidence on pathogenesis models (Pelletier et al., 1991). DeepScan applies 7-step verification to BMP-7 nephrogenesis data (Luo et al., 1995), checkpointing CoVe on imprinting claims. Theorizer generates hypotheses linking WT1 to 11p15 from citationGraph inputs.

Try Doxa for Wilms Tumor Molecular Pathogenesis Research

Frequently Asked Questions

What defines Wilms Tumor Molecular Pathogenesis?

It encompasses genetic drivers like WT1 mutations, CTNNB1 alterations, and 11p15 imprinting defects causing nephroblastoma (Pelletier et al., 1991).

What are key methods in this subtopic?

Methods include murine gene expression analysis, knockout models for nephrogenesis, and genomic mutation profiling (Luo et al., 1995; Little and McMahon, 2012).

What are foundational papers?

Pelletier et al. (1991, 449 citations) maps WT1 in urogenital system; Luo et al. (1995, 1023 citations) shows BMP-7 in kidney induction.

What open problems exist?

Challenges include full multi-hit mouse models and therapeutic WT1 restoration despite apoptosis induction (Englert et al., 1995; Martínez-Estrada et al., 2009).